Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 6 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Keros Therapeutics Inc have a median target of 88.00, with a high estimate of 105.00 and a low estimate of 76.00. The median estimate represents a 53.52% increase from the last price of 57.32.
High | 83.2% | 105.00 |
Med | 53.5% | 88.00 |
Low | 32.6% | 76.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 04, 2024.
Average growth rate | +0.23% |
Average growth rate | -25.33% |
More ▼
Revenue history & estimates in USD
Average growth rate | -32.46% |
Average growth rate | -100.00% |
More ▼